final program

 

Click here to download Final Program as a pdf.

Click here to download entire Final Program Book as a pdf.


Saturday,
July 30, 2016
Sunday,
July 31, 2016
Monday,
August 1, 2016
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Sunday, July 31, 2016

08:30-10:30   HALL A
 

PL07    Plenary Session:
AORTIC ANEURYSMS AND PERIPHERAL VASCULAR DISEASE: PATHOGENESIS, DIAGNOSIS AND TREATMENT
 

Chairs:
J.A. Elefteriades, New Haven, CT, USA
S.D. Gertz, Jerusalem, Israel

 
08:30 ASTHMA AS A RISK FACTOR OF HUMAN AND EXPERIMENTAL ABDOMINAL AORTIC ANEURYSM (Invited Lecture)
C-L. Liu, H. Wemmelund, J.S. Lindholt, A. Daugherty, B.D. Levy, P. Libby, G-P. Shi, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
160
08:45 CXCR6/CXCL16 AXIS IS INVOLVED IN MONONUCLEAR CELL ADHESION INDUCED BY ANGIOTENSIN II, POTENTIAL IMPLICATION IN ABDOMINAL AORTIC ANEURYSM (AAA) FORMATION? (Invited Lecture)
M.J. Sanz, A. Collado, P. Escudero, C. Rius, P. Marques, L. Piqueras, Faculty of Medicine, University of Valencia, Valencia, Spain
161
09:00 THE CENTRAL ROLE OF SMOOTH MUSCLE CELL MITOCHONDRIA IN THE PREVENTION OF ABDOMINAL AORTIC ANEURYSM BY LOW LEVEL LASER THERAPY (Invited Lecture)
L. Gavish, R. Beeri, D. Gilon, C. Rubinstein, Y. Berlatzky, S.D. Gertz,The Hebrew University of Jerusalem and Hadassah University Hospital, Jerusalem, Israel
162
09:15 WHAT IS THE PROGRESS WITH TREATMENTS FOR SMALL ABDOMINAL AORTIC ANEURYSMS? (Invited Lecture)
J. Golledge, James Cook University, School of Medicine Townsville, Queensland, Australia
163
09:30 WHOLE EXOME SEQUENCE FOR THORACIC AORTIC ANEURYSMS (Invited Lecture)
B.A. Ziganshin, A.E. Bailey, C. Coons, D. Dykas, P. Charilaou, L.H. Tanriverdi, L. Liu, M. Tranquilli, A.E. Bale, J.A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA
164
09:45 DILATING VENOUS DISEASE: PATHOPHYSIOLOGY AND A SYSTEMATIC ASPECT TO DIFFERENT VASCULARTERRITORIES (Invited Lecture)
E. Yetkin, International Medical Center, Mercin, Turkey
165
10:00 MANAGEMENT OF VENOUSTHROMBOEMBOLISM (Invited Lecture)
T. Tomaru, T. Matsubara, E. Matsubara, S .Kodera, Toho University Sakura Hospital, Sakura, Japan
166
10:15

THE 2016 BEST TOOL FOR PERIPHERAL VASCULAR INTERVENTION (Invited Lecture)
S.M. Butman, Verde Valley Medical Center, Cottonwood, AZ, Banner University Medical Center, Tucson, AZ, USA

168
10:30 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
08:30-11:15   HALL B

 

PL08   Plenary Session:
ATHEROSCLEROSIS: FROM BASIC MECHANISMS TO NOVEL OPPORTUNITIES FOR INTERVENTIONS

Chairs:
C. Chen, Houston, TX, USA
T. Malinski, Athens, OH, USA

 

08:30 NOVEL REGULATION OF VASCULAR CALCIFICATION (Invited Lecture)
Y. Chen, University of Alabama at Birmingham, Birmingham, AL, USA
169
08:45 PREVENTION AND INTERFERENCE OF ATHEROSCLEROTIC HEART DISEASE IN MULTIPLE ANIMAL MODELS (Invited Lecture)
S. Chatterjee, D. Bedja, S. Mishra, C. Amuzie, C.A. Foss, M.G. Pomper, R. Bhattacharaya, K.J. Yarema, Johns Hopkins University, Baltimore, MD, USA
170
09:00 GLYCOSAMINOGLYCANS (GAGS) IN CARDIOVASCULAR DISEASE: SEARCHING FOR THE SWEET SPOT (Invited Lecture)
A. Lucas, University of Florida, Gainesville, FL, USA
171
09:15 OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION (Invited Lecture)
C. Chen, J. Lu, Q. Yao, Baylor College of Medicine, Houston, TX, USA
172
09:30 A NANOMEDICAL APPROACH TO THE RESTORATION OF DYSFUNCTIONAL ENDOTHELIUM AND THE FUNCTION OF THE CARDIOVASCULAR SYSTEM (Invited Lecture)
T. Malinski, S. Awad, H. Dawoud, Ohio University, Athens, OH, USA
173
09:45

EFFECT OF ENDOTHELIAL CELL SENESCENCE ON THE HEAT SHOCK RESPONSE AND CELLULAR FUNCTION (Invited Lecture)
A.A. Knowlton, H.T. Hwang, Sacramento VA Medical Center, Mather, CA USA and University of California, Davis, CA, USA

174
10:00 INVOLVEMENT OF STROMAL INTERACTION MOLECULE-1 IN ANGIOTENSIN-IIINDUCED EXPRESSION OF EARLY GROWTH RESPONSE PROTEIN-1 IN VASCULAR SMOOTH MUSCLE CELLS (Invited Lecture)
E.R. Simo-Cheyou, A.K. Srivastava, CRCHUM, University of Montreal, Montreal, Quebec, Canada
175
10:15 MICRORNA REGULATION OF ENDOTHELIAL INFLAMMATION AND ATHEROSCLEROSIS (Invited Lecture)
M. Feinberg, Brigham and Women's Hospital, Boston, MA, and Harvard Medical School, Boston, MA , USA
176
10:30 IMPACT OF REACTIVE OXYGEN SPECIES ON CORONARY ARTERIAL REMODELING - A COMPARATIVE INTRAVASCULAR ULTRASOUND AND HISTOCHEMICAL ANALYSIS OF ATHEROSCLEROTIC LESIONS (Invited Lecture)
M. Terashima, Toyohashi Heart Center, Toyohashi, Japan
177
10:45 MOLECULAR MECHANISMS OF VASCULAR DYSFUNCTION AND ATHEROSCLEROSIS REGULATED BY HEMODYNAMICS FORCES (Invited Lecture)
Z-G. Jin, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
178
11:00

ADAR1-MEDIATED RNA EDITING, A NOVEL MECHANISM CONTROLLING VASCULAR SMOOTH MUSCLE PHENOTYPIC MODULATION (Invited Lecture)
J. Fei, X.B. Cui, K. Dong, S.Y. Chen, University of Georgia, Athens, GA, USA

179
11:15 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
08:30 - 10:15   HALL C
  S26   Session:  
CARDIOVASCULAR IMAGING MODALITIES FOR EVALUATION OF CORONARY CIRCULATION, CARDIAC STRUCTURE AND FUNCTION

Chairs:
Y. Charuzi, Los Angeles, CA, USA
P.A. Pellikka, Rochester, MN, USA
 
08:30 ATRIAL FIBRILLATION INFLUENCES RIGHT ATRIAL PRESSURE ESTIMATION BY HAND HELD ULTRASOUND ASSESSMENT OF THE VENA CAVA
D.W. Kehl, R. Zimmer, G. Sheth, S.R. Shadix, R. Khandwalla, I. Kedan, Cedars-Sinai Medical Center, Los Angeles, CA, USA
180
08:45 NEW SOFTWARE BASED BEAMFORMING ALGORITHM IS SUPERIOR TO HARDWARE BASED BEAMFORMER IN ENDOCARDIAL BORDER DETECTION
R.A. Kulina, B. Wiley, S. Agarwal, A. Traube, S .Ka, S. Schiller, L. Clark,
J. Narula, P. Sengupta, F. Chaudhry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
181
09:00 A MIXED TREATMENT ANALYSIS COMPARING THE EFFICACIES OF IVABRADINE VERSUS BETA BLOCKERS WHEN USED AS PREMEDICATION FOR HEART RATE REDUCTION IN COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY
S. Dayanand, J.M. Martinez, University of Central Florida, Kissimme, FL, USA
182
09:15 THE ROLE OF ECHOCARDIOGRAPHY IN THE MANAGEMENT OF PATIENTS UNDERGOING VENTRICULAR ASSIST DEVICE IMPLANTATION AND/OR TRANSPLANT SURGERY (Invited Lecture)
T.S. Kato, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
183
09:30 COST EFFECTIVENESS OF CORONARY CT ANGIOGRAPHY IN PATIENTS WITH LOW RISK FOR CORONARY ARTERY DISEASE (CAD) AT A TERTIARY CARE CENTER
K. Kalvakuri, S. Banga, S. Singh, W. Keattiyoat, M.F. Malik, University of Illinois College of Medicine at Peoria, Illinois, USA
184
09:45 HYPEREMIC INSTANTANEOUS WAVE-FREE RATIO PROVIDES THE HEMODYNAMIC OUTCOME FOR MODERATE TO SEVERE CORONARY ARTERY STENOSES
Y. Kanamori, R. Aikawa, Kuwana City Medical Center, Japan
185
10:00

GLOBAL LONGITUDINAL STRAIN AS A PREDICTOR OF MAJOR ADVERSE EVENTS IN ESRD PATIENTS WITH PRESERVED EJECTION FRACTION
S. Furlan, F. Abdelmalak, E. Donath, R. Chait, University of Miami, Palm Beach Regional Campus, Atlantis, FL, USA

186
10:15 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
08:30-11:00   HALL D
 

S27   Session:  
ADVANCES IN HEART FAILURE, CARDIOMYOPATHIES AND PULMONARY HYPERTENSION

Chairs:
Y. Birnbaum, Houston, TX, USA
A.M. Gerdes, Old Westbury, NY, USA

 
08:30 PULMONARY AND HEMODYNAMIC RESPONSES TO FRUCTOSE-1,6-DIPHOSPHATE (FDP) IN PATIENTS WITH ACUTE LUNG INJURY (ALI)
A.K. Markov, T.N. Skelton, University of Mississippi School of Medicine Department of Medicine, Jackson, MS, USA
187
08:45 MORTALITY OF PULMONARY EMBOLISM TREATED WITH SYSTEMIC OR INTRAPULMONARY THROMBOLYSIS: A SINGLE CENTER, 10-YEAR RETROSPECTIVE STUDY
S. Udae, J. Cholteesupachai, S. Srimahachota, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
188
09:00 SHORT TERM LOW DOSE ATORVASTATIN THERAPY IMPROVES ENDOTHELIAL DYSFUNCTION IN NORMOLIPIDEMIC PATIENTS WITH PRESERVED EJECTION FRACTION HEART FAILURE
S. Yazdankhah, S.H. Majidi, M.H Adel, A. Kardooni, H. Karbalivand,
M. Maghsoodi, A. Rouhizadeh, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan
189
09:15 A COMPARATIVE ANALYSIS OF CHRONIC HEART FAILURE IN A PREDOMINANT AFRICANAMERICAN POPULATION
D. Brito, E. Ladron-Franco, T. Alnabelsi, J. Penalver, A. Macedo-Dias, H.D. Hares, B. Bozorgnia, Department of Internal Medicine, Einstein Medical Center, Philadelphia, PA, USA
190
09:30 DOXORUBICIN-INDUCED CARDIOMYOPATHY IN CHRONIC LYMPHOCYTIC LEUKEMIA AND RICHTER'S TRANSFORMATION: DEVELOPMENT OF HEART FAILURE WITH SYSTOLIC AND DIASTOLIC DYSFUNCTION
S.H. Wan, R.L. Frye, Mayo Clinic, Rochester, MN, USA
191
09:45 PRENATAL TRANS-PLACENTAL DIGOXIN THERAPY FOR FETAL HEART FAILURE: A COHORT STUDY
K.Y. Zhou, C. Wang, Y.F. Li, Y.M. Hua, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
192
10:00 PATIENT PERCEPTIONS ABOUT A HOSPITAL-AT-HOME MODEL OF CARE FOR DECOMPENSATED HEART FAILURE
T. Rahman, Q. Ibrahim, H. Van Spall, McMaster University, Department of Medicine, Hamilton, ON, Canada
193
10:15 A CASE OF TUBERCULOUS PERICARDITIS MIMICKING LUPUS CARDITIS
C. Panagiota, I. Katsa, J. Miles, R. Faillace, Albert Einstein College of Medicine Jacobi Medical Center, Bronx, NY, USA
194
10:30 CLINICAL CHARACTERISTICS OF TAKOTSUBO CARDIOMYOPATHY IN THAILAND
A. Ardjnaphai, J. Chaipromprasit, Division of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
195
10:45 EMBOLIC PARADOX: WHEN TWO WRONGS MAKE A RIGHT
V. Tavakoli, R. Bindu, C. Philip, R. Grodman, D. Bloomfield, Richmond University Medical Center, Staten Island, NY, USA
196
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
11:15-13:30   HALL A

 

PL09   Plenary Session:
VALVULAR, STRUCTURAL AND CONGENITAL HEART DISEASE: NEW CHALLENGES AND NEW DIRECTIONS

Chairs:
J.S. Borer, New York, NY, USA
L.P. Perrault, Montreal, QC, Canada

 

11:15 MITRAL INTERVENTION IN CABG PATIENTS: IS LESS EVER MORE? (Invited Lecture)
L.P. Perrault, Montreal Heart Institute, East, Montreal, QC, Canada
197
11:30 VALVULAR HEART DISEASES 2016: EPIDEMIOLOGY AND IMPACT OF INTERVENTIONS (Invited Lecture)
J.S. Borer, P.G. Supino, SUNY Downstate, New York, NY, USA
198
11:45 LOW GRADIENT SEVERE AORTIC STENOSIS: ECHO FEATURES AND CLINICAL SIGNIFICANCE (Invited Lecture)
P.A. Pellikka, Mayo Clinic, Rochester, MN, USA
199
12:00 ATRIAL FUNCTIONAL MITRAL REGURGITATION: THE LEFT ATRIUM GETS ITS DUE RESPECT (Invited Lecture)
B.D. Hoit, University Hospitals Case Medical Center, Case Western Reserve University. Cleveland, OH, USA
200
12:15 OSTEOGENIC DIFFERENTIATION IS A MECHANISM FOR BIOPROSTHETIC VALVE CALCIFICATION (Invited Lecture)
N.M. Rajamannan, Mayo Clinic, Rochester, MN, USA
201
12:30 AVOIDING AND SOLVING COMPLICATIONS DURING PERCUTANEOUS CLOSURE OF ASD (Invited Lecture)
A. Lorber, Rambam Medical Campus, Haifa, Israel
203
12:45

INCREMENTAL VALUE OF MRI IN STAGING THE SEVERITY OF AORTIC STENOSIS
M. Katayama, P.M. Panse, C.B. Kendall, J.R. Daniels, J.P. Sweeney,
F.D. Fortuin, M. Belohlavek, H.P. Chaliki, Mayo Clinic, Scottsdale, AZ, USA

204
13:00 IMPACT OF PREOPERATIVE PULMONARY ARTERIAL HYPERTENSION ON OUTCOME OF MITRAL VALVE REPLACEMENT
M.A. Gebrie, N. Ahmed, A. Rungatscher, G.B. Luciani, G. Faggian, Division of Cardiac Surgery, University of Verona, Verona, Italy
205
13:15

EARLY OUTCOMES AFTER THE COMMANDO PROCEDURE: DOUBLE VALVE REPLACEMENT AND RECONSTRUCTION OF INTERVALVULAR FIBROSA
D.A. Steimer, T. Chamogeorgakis, J.C. MacHannaford, A. Rafael,
S.R. Malyala, G.V. Gonzalez-Stawinski, B. Lima, Baylor University, Dallas, TX, USA

206
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
11:15-13:45   HALL B

 

PL10  Plenary Session:
ATRIAL FIBRILLATION AND SUPRAVENTRICULAR TACHYCARDIA: FROM MECHANISMS TO MANAGEMENT

Chairs:
M.A. Alpert, Columbia, MO, USA
T. Deneke, Bad Neustadt, Germany

 

11:15 ASYMPTOMATIC ACUTE COMPLICATIONS OF ATRIAL FIBRILLATION ABLATION USING IRRIGATED RADIOFREQUENCY TECHNOLOGY (Invited Lecture)
T. Deneke, P. Halbfaß, P. Müller, G. Szöllösi, M. Roos, J. Krug, A. Schade, A. Müller, F. Fochler, K. Nentwich, Cardiovascular Center Bad Neustadt, Germany
207
11:30 ANTI-THROMBOTIC THERAPY FOR ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: CURRENT VIEWS (Invited Lecture)
M.A. Alpert, University of Missouri, Columbia, MO, USA
208
11:45 COMPLICATIONS AFTER RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION: ATRIAL-ESOPHAGEAL AND PERICARDIOESOPHAGEAL FISTULAS (Invited Lecture)
K. Seidl, Klinikum-Ingolstadt, Germany
209
12:00 THE MOST COST EFFECTIVE APPROACH TO RISK ASSESSING PATIENTS WITH WOLFFPARKINSON-WHITE SYNDROME (Invited Lecture)
C.S. Snyder, The Congenital Heart Collaborative, Case Western Reserve University, Cleveland OH, USA
210
12:15 CARDIAC AUTONOMIC NERVE STIMULATION AND ATRIAL FIBRILLATION: EFFECT OF IN VIVO SIMULTANEOUS SYMPATHETIC AND VAGAL EXCITATION (Invited Lecture)
Y. Zhang, Cleveland Clinic, Cleveland, OH, USA, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA
211
12:30 METABOLOMIC PROFILING IN RELATION TO NEW-ONSET ATRIAL FIBRILLATION IN THE COMMUNITY: THE FRAMINGHAM HEART STUDY
D. Ko, E.M. Riles; E.G. Marcos; J.W. Magnani; S.A. Lubitz; H. Lin;
M.T. Long; R.B. Schnabel; D.D. McManus; P.T. Ellinor;
V.S. Ramachandran; T.J. Wang; R.E. Gerszten; E.J. Benjamin; X. Yin;
M. Rienstra; Boston Medical Center, Boston University School of Medicine, Boston, MA; USA
212
12:45

TEMPORAL TRENDS IN PREVALENCE OF COMORBIDITIES IN ATRIAL FIBRILLATION PATIENTS ADMITTED WITH FIRST ISCHEMIC STROKE
S. Agrawal, L. Garg, N. Maheshwari, D. Mohananey, A. Singh, A. Sinha,
A. Quddus, S. Nanda, J. Shirani, St. Luke’s University Health Network, Bethlehem, PA, USA

213
13:00 COLCHICINE VERSUS PLACEBO FOR PREVENTION OF POST-PROCEDURAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
O. Kreidieh, M. Kabach, S. El Dassouki, J. Martinez, R. Rosenstein,
R. Chait, University of Miami Miller, Palm Beach Regional Campus, Atlantis, Florida, USA
214
13:15 GASTROINTESTINAL BLEEDING PROPHYLAXIS IN ATRIAL FIBRILLATION PATIENTS RECEIVING DABIGATRAN
T. Nantsupawat, S. Soontrapa, N. Nantsupawat, S. Klomjit,
P. Tantrachoti, D. Sotello, H. Mazek, A.P. Perez-Verdia, Texas Tech University Health Sciences Center, Lubbock, TX, USA
215
13:30

IMPACT OF CHA2DS2VASC SCORE ON ATRIAL FIBRILLATION DETECTION IN PATIENTS WITH CRYPTOGENIC STROKE
A. Abichandani, D. Signarovitz, K. Branch, D. Prutzman, S. Agrawal,
L. Sadowski, S. Stevens, D. Traub, J. Shirani, S. Nanda, St. Luke's University Health Network, Bethlehem, PA, USA

216
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
11:15 - 13:30   HALL C
  S28   Session:
CARDIOVASCULAR DISEASE: PREVENTION AND RISK FACTORS

Chairs:
C.H. Hennekens, Boca Raton, FL, USA
N.D. Wong, Irvine, CA, USA
 
11:15 STATIN CANDIDATES IN “PRIMARY PREVENTION” DOUBLES WITH THE “ACC/AHA GUIDELINE ON THE TREATMENT OF BLOOD CHOLESTEROL TO REDUCE ATHEROSCLEROTIC CARDIOVASCULAR RISK”: COMPARISON OF TWO AMERICAN GUIDELINES IN TURKISH POPULATION
C. Barcin, F. Bayram, A. Sonmez, C. Gokce, K. Gundogan, Gulhane Military Medical Academy, Ankara, Turkey
217
11:30 ASSESSING THE CARDIOVASCULAR HEALTH BEHAVIORS OF COLLEGE STUDENTS
M. Granieri, J.P. Cordova, A. Koulova, C. Bavishi, S. Trignano,
J.E. Tamis-Holland, Mount Sinai St. Luke’s Hospital, NY, USA
218
11:45 HOW EFFECTIVE IS LIFESTYLE INTERVENTION IN WEIGHT MANAGEMENT AND DEPRESSION IN ADULTS WITH METABOLIC SYNDROME
Q. Wang, S.Y. Chair, E.M.L. Wong, The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong
219
12:00 UPDATE ON ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
C.H. Hennekens, Florida Atlantic University, Boca Raton, FL, USA
220
12:15 EFFICACY OF A CARDIOVASCULAR BEHAVIORAL INTERVENTION PROGRAM ON PROGRESSION OF ATHEROSCLEROSIS
N.D. Wong, A. Eisenberg, J. Cecere, C. Patao, H. Eisenberg, University of California, Irvine, CA, USA
221
12:30 THE EFFECT OF SELF-MONITORING OF BLOOD PRESSURE ON MEDICATION ADHERENCE AND LIFESTYLE FACTORS: SYSTEMATIC REVIEW, META-ANALYSIS AND QUALITATIVE INTERVIEWS
B.R. Fletcher, J. Hartmann-Boyce, L. Hinton, R.J. McManus, University of Oxford, Oxford, UK
222
12:45 CAROTID INTIMA MEDIA THICKNESS MEASUREMENT PROMISES TO IMPROVE CARDIOVASCULAR RISK EVALUATION IN HEAD AND NECK CANCER PATIENTS
D. Jacoby, J. Hajj, A. Javaheri, E. Degoma, A. Lin, P. Ahn, H. Quon, University of Pennsylvania, Philadelphia, PA, USA
223
13:00 EFFICACY OF A CARDIOVASCULAR BEHAVIORAL INTERVENTION PROGRAM ON MEASURES OF STRESS
A. Eisenberg, N.D. Wong, C. Pateo, J. Cecere, H. Eisenberg, Re-Engineering Healthcare, Tustin, California, USA
224
13:15

EFFECT OF VARIOUS CHILDHOOD ANTHROPOMETRIC MEASURES ON ADULTHOOD CAROTID INTIMA-MEDIA THICKNESS: A SYSTEMATIC REVIEW AND META-ANALYSIS
J. Kaur, S. Singh, P. Nieminen, K.K. Thumburu, A. Chauhan, N. Jaiswal, A. Agarwal, M. Singh, N. Paul, S. Sagwal, ICMR Advanced Centre for Evidenced Based Child Health, Advanced Pediatric Centre, PGIMER, Chandigarh, India

225
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
11:15 - 13:30   HALL D
 

S29   Session:  
CELLULAR, MOLECULAR AND GENETIC MECHANISMS OF CARDIOVASCULAR DISEASE

Chairs:
L.W. Miller, Clearwater, FL, USA
D.K. Singla, Orlando, FL, USA

 
11:15 DEPLETION OF THE CEREBLON GENE ENHANCES CARDIAC CONTRACTILITY, CA2+ TRANSIENT AND MITOCHONDRIAL ENERGY METABOLISM IN MICE
H.K. Kim, T.H. Ko, Y.H. Noh, S.H. Jeong, N. Kim, B.D. Rhee, K.S. Ko,
J. Han, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University, Busan, Korea
226
11:30 MITF SWITCHES FROM ACTIVATOR TO REPRESSOR OF ERBIN EXPRESSION DURING CARDIAC HYPERTROPHY
I. Rachmin, E. Amsalem, E. Golomb, R. Beeri, D. Gilon, G. Min,
R.S.Y. Foo, D.E. Fisher, E. Razin, S. Tshori, Hebrew University Medical School, Jerusalem, Israel
227
11:45 INHIBITION OF LEPTIN RECEPTOR ABOLISHES INTRALIPID-INDUCED CARDIOPROTECTION AGAINST ISCHEMIA- REPERFUSION INJURY
N. Motayagheni, S. Phan, C. Eshraghi, M. Eghbali, UCLA, CA, USA
228
12:00 CYP2C19 GENETIC VARIATION AND INDIVIDUALIZED CLOPIDOGREL PRESCRIPTION IN A CARDIOLOGY CLINIC
S.A. Mirabbasi, K. Khalighi, B. Khalighi, A. Kodali, Y. Wu, W. Fan, Easton Hospital, Drexel University, Easton, PA, USA
229
12:15 A GENOME-WIDE METHYLATION ANALYSIS SHOWS DIFFERENTIALLY METHYLATED REGIONS BETWEEN FUTURE CVD CASES AND CONTROLS
O. Coltell, J.V. Sorli, E.M. Asensio, R. Fernandez-Carrion,
C. Ortega-Azorin, R. Barragan-Arnal, I. Gonzalez-Monje, F. Aros,
J.M. Ordovas, D. Corella, CiberOBN, Madrid, Spain
230
12:30

RELATIONSHIP BETWEEN ASPIRIN RESPONSE RELATED MICRORNA AND THE RISK OF CARDIOVASCULAR EVENTS IN CAD PATIENTS
J.W. Zhang, T.F. Liu, W.Y. Liang, X.R. Feng, L. Wang, P.Z. Wang, S.W. Fu, T.A. McCaffrey, M.L. Liu, Department of Geriatrics, Peking University First Hospital, Beijing, China

231
12:45 A GENETIC VARIANT IN THE CIRCADIAN GENE BMAL1 IS ASSOCIATED WITH HIGHER INCIDENCE OF CARDIOVASCULAR DISEASES
D. Corella, J.V. Sorli, F.G. Frances, R. Fernandez-Carrion, R. Estruch,
L. Parnell, F. Aros, C. Saiz, J.M. Ordovas, O. Coltell, CiberOBN, Madrid, Spain
232
13:00 MMP1 GENE POLYMORPHISM AND CIRCULATING MMP IN ELDERS WITH LIPEMIA AND PATIENTS WITH IHD
G.A. Paul, N.V. Goncharova, V.M. Belichenko, T.A. Korolenko, Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia
233
13:15

EVALUATION OF GENETIC PROFILES IN MEDICATION ADJUSTMENTS
A.J. Allen, J.M. Wetmore, M.F. Maturi Allen, D.R. Talreja, Yale University New Haven, CT, USA

234
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 31, 2016
14:00 - 16:30   HALL A
 

PL11   Plenary Session:
TREATING ADVANCED HEART FAILURE – THE PUMPS AND BEYOND

Chairs:
M.R. Johnson, Madison, WI, USA
H.N. Sabbah, Detroit, MI, USA

 
14:00 USE OF THE NONIONIC BLOCK COPOLYMER, VEPOLOXAMER (P-188) FOR THE TREATMENT OF ADVANCED HEART FAILURE (Invited Lecture)
H.N. Sabbah, R.C. Gupta, V. Sing-Gupta, M. Emanuele, Henry Ford Hospital, Detroit, MI, USA
269
14:15 THE PRESENT AND FUTURE OF THE TOTAL ARTIFICIAL HEART (Invited Lecture)
F. Arabia, I. Gregoric, V. Kasirajan, J. D Moriguchi, D. C Naftel, S. L Myers, J. K Kirklin, Cedars-Sinai Medical Center, Los Angeles, CA, USA
270
14:30 THE BENEFITS AND RISKS OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION; WHERE IS THE POINT OF CLINICAL EQUIPOISE? (Invited Lecture)
M.R. Johnson, University of Wisconsin, Madison, WI, USA
271
14:45 OPTIONS FOR REMOTE PATIENT MONITORING IN THE LVAD POPULATION (Invited Lecture)
S.P. Bhavnani, A. Srivastava, D. Meyer, R. Kuo, J. Nowaczyk, L. Wolman, S. Baradarian, T. Heywood, Methodist Health System, Dallas, Texas, USA
272
15:00 TRANSITION TO STAGE D HEART FAILURE AMONG STABLE OUTPATIENTS WITH SYSTOLIC HEART FAILURE (Invited Lecture)
A.P. Kalogeropoulos, A.A. McCue, J.S. Hedley, A. Samman-Tahhan, J.B. Bjork, V.V. Georgiopoulou, J.D. Vega, A.L. Smith, Emory University, Atlanta, GA, USA
273
15:15 MYOCARDIAL RECOVERY DURING VENTRICULAR UNLOADING IN PATIENTS WITH CHRONIC CARDIOMYOPATHY: ASSESSMENT OF CARDIAC IMPROVEMENT AND WEANING FROM VENTRICULAR ASSIST DEVICES (Invited Lecture)
M. Dandel, Deutsches Herzzentrum Berlin, Berlin, Germany
274
15:30 TREATING FLUID OVERLOAD WITH FLUID; ROLE OF PERITONEAL DIALYSIS IN MANAGEMENT OF HEART FAILURE (Invited Lecture)
A. Kazory, University of Florida, Gainesville, Florida, USA
275
15:45 ACELLULAR BIOLOGICS FOR CARDIAC REGENERATION (Invited Lecture)
A. Behfar, Mayo Clinic, Rochester, MN, USA
276
16:00 WHOLE HEART REGENERATION WITH HUMAN iPS CELL-DERIVED HEART PROGENITORS (Invited Lecture)
B. Lin, T-Y Lu, J. Kim, M. Sullivian, K. Tobita, G. Salama, L. Yang, University of Pittsburgh, Pittsburgh, PA, USA
277
16:15 NEWER IMPLANTABLE DEVICES IN HEART FAILURE (Invited Lecture)
K. Srivathsan, Mayo Clinic, Phoenix, AZ, USA
278
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 31, 2016
14:00 - 16:00   HALL B
  PL12   Plenary Session:
MULTIMODALITY IMAGING FOR EVALUATION OF CARDIOVASCULAR DISEASE

Chairs:
A. Elhendy, Marshfield, WI, USA
J.M. Gardin, Teaneck, NJ, USA
 
14:00 ROLE OF ECHOCARDIOGRAPHY IN EPIDEMIOLOGIC STUDIES AND CLINICAL TRIALS: AN HISTORICAL PERSPECTIVE (Invited Lecture)
J.M. Gardin, Hackensack University Medical Center, Rutgers New Jersey Medical School, NJ, USA
279
14:15

CARDIAC IMAGING FOR EVALUATION OF CORONARY ARTERY DISEASE IN PATIENTS WITH HYPERTENSION (Invited Lecture)
A. Elhendy, Marshfield Clinic, Marshfield, WI, USA

281
14:30 MULTIMODALITY IMAGING IN CARDIOMYOPATHY (Invited Lecture)
J. Shirani, St. Luke's University Health Network, Bethlehem, PA, USA
282
14:45

ECHOCARDIOGRAPHIC QUANTITATION OF AORTIC REGURGITATION (Invited Lecture)
H. Chaliki, Mayo Clinic College of Medicine, Mayo Clinic, Scottsdale, AZ, USA

283
15:00 CURRENT STATUS OF INTRAVASCULAR IMAGING (Invited Lecture)
S.K.G. Koshy, L.K. George, Regional One Health - University of Tennessee Health Sciences Center, Memphis TN, USA
284
15:15 THE USE OF POINT OF CARE ULTRASOUND TO GUIDE MANAGEMENT IN HEART FAILURE (Invited Lecture)
I. Kedan, R. Khandwalla, R. Zimmer, K. Birkeland, Cedars Sinai Heart Institute, Beverly Hills, CA, USA
285
15:30

POSITIVE STRESS ECHO AND NORMAL CORONARY ARTERIES: HOW OFTEN AND WHY? (Invited Lecture)
M. Prokudina, E. Bobrova, E. Shloido, I. Konstantinov, P. Mochalov, Almazov North-West Medical Research Center, St-Petersburg, Russia

286
15:45

INTRAVASCULAR OPTICAL IMAGING TECHNOLOGY FOR DETECTION OF HIGH-RISK PLAQUE (Invited Lecture)
H. Yoo, Hanyang University, Seoul, South Korea

287
16:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 31, 2016
14:00 - 16:15   HALL C
  S30 Session:
RISK STRATIFICATION AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE

Chairs:
R.S. Rosenson, New York, NY, USA
L. Sperling, Atlanta, GA, USA

 
14:00 ASTHMA ASSOCIATES WITH HUMAN ABDOMINAL AORTIC ANEURYSM AND RUPTURE
C.L. Liu, H. Wemmelund, J. Lindholt, B. Levy, P. Libby, G.P. Shi, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
288
14:15 ASSOCIATION BETWEEN HIGH-DENSITY LIPOPROTEIN AND CARDIOVASCULAR DISEASE OUTCOMES
M.S. Sidhu, M. Pragani, W.E. Boden, R.P. Smith, L.H. Bopp, M.E. Rafferty, Albany Medical Center and Albany Stratton Veterans Affair Medical Center, Albany, NY, USA
289
14:30 FAILING TO MEET HEART FAILURE PATIENTS' BASIC NUTRITIONAL NEEDS-WHO'S LISTENING?
A. Kodra, J. Jacobson, R. Graham, Lenox Hill Hospital, New York, NY, USA
290
14:45 THE RUMC INDEX: PREDICTING MORTALITY USING A COMBINED EWS AND NLR SCORING SYSTEMS
A.J. Park, X. Wang, V. Arulthasan, D.A. Bloomfield, Richmond University Medical Center, Staten Island, NY, USA
291
15:00 TRIAGE AFTER EXERCISE TREADMILL TEST (TEXT) STUDY: A SINGLE CENTER EXPERIENCE WITHIN AN INTEGRATED HEALTHCARE DELIVERY SYSTEM
A. Krishnaswami, W. Ho, W. Kwan, C. Tsou, O. Anaya, S.F. Jiang,
J.J. Jang, W. Praserthdam, Division of Cardiology, Kaiser Permanente, San Jose, CA, USA
292
15:15 GENERALIZED ANXIETY DISORDER IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION: A POPULATION-BASED COHORT STUDY
W-C. Tzeng,National Defense Medical Center, Taipei, Taiwan
293
15:30 COMPARISON BETWEEN RISK FACTORS AND ANGIOGRAPHIC CHARACTERIZATION OF YOUNG VERSUS OLD PATIENTS WITH STEMI
S.H. Majidi, S. Yazdankhah, M.H. Adel, R. Hajizadeh, M. Syeidian,
N. Akiash, M. Noorizadeh, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran
294
15:45 HEARTFIT: PRELIMINARY RESULTS OF A PILOT CARDIAC OUTPATIENT SELFMANAGEMENT PROGRAMME
J. Choy, M. Tay, Tan Tock Seng Hospital, Singapore
295
16:00 DEVELOPMENT OF A HOLISTIC MODEL TO PREVENT AND REVERSE CORONARY ARTERY DISEASE: SAAOL (SCIENCE AND ART OF LIVING) SAFETY CIRCLE
B. Chhajer, SAAOL Heart Center, New Delhi, India
296
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 31, 2016
14:00 - 15:45   HALL D
  S31 Session:
MOLECULAR CARDIOLOGY AND VASCULAR BIOLOGY, BASIC RESEARCH

Chairs:
A.A. Knowlton, Davis, CA, USA
C.S. Long, Denver, CO, USA

 
14:00 DEFICIENCY OF FILAMIN A IN ENDOTHELIAL CELLS IMPAIRS LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION
S. Bandaru, J. Grönros, B. Redfors, Ç. Çil, D. Pazooki, R. Salimi,
E. Larsson, A.X. Zhou, E. Ömerovic, L.M. Akyürek, University of Gothenburg, Sweden
297
14:15 A TRANSGENIC MOUSE MODEL OF ATHEROSCLEROTIC PLAQUE CALCIFICATION
F. Romanelli, A.M. Corbo, A.Y. Savinov, J.L. Millan, O.V. Savinova, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA
298
14:30 THYROID HORMONE INDUCES VASCULAR RELAXATION THROUGH VASP PHOSPHORYLATION AT SERINE 239: A POTENTIAL THERAPEUTIC APPROACH TO TREAT DIABETIC VASCULAR DYSFUNCTION
M.A. Carrillo-Sepulveda, S. Samuel, A. Martin Gerdes, New York Institute of Technology, Old Westbury, NY, USA
299
14:45 INTRALIPID PROTECTS THE HEART AGAINST ISCHEMIA/REPERFUSION INJURY BY REDUCING CARDIOMYOCYTE APOPTOSIS VIA MIR122 INDUCTION IN LATE PREGNANCY
J. Li, N. Motayagheni, N. Barakati, M. Eghbali, UCLA, Los Angeles, CA, USA
300
15:00 THE ACTION OF NUTRACEUTICALS ON KEY MACROPHAGE PROCESSES ASSOCIATED WITH ATHEROSCLEROSIS
T.S. Davies, H. Gallagher, J.W.E. Moss, F.B. Jaffar, W. Al-Ahmadi,
F. Harris, D.P. Ramji, Cardiff University, Cardiff, UK
301
15:15 HEME OXYGENASE-1 DEFICIENCY EXACERBATES ABDOMINAL AORTIC ANEURYSM
Y.C. Ho, M.L. Wu, S.F. Yet, National Health Research Institutes, Zhunan, Taiwan
302
15:30 PROTEOMIC PROFILING OF THE AGED MDX-4CV HEART MODEL OF DYSTROPHINOPATHY-RELATED CARDIOMYOPATHY
S. Murphy, P. Dowling, K. Ohlendieck, Maynooth University, Maynooth, Co. Kildare, Ireland
303
15:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 31, 2016
16:45-18:30   HALL B
 

PL13   Plenary Session:
SYSTEMIC AND PULMONARY ARTERY HYPERTENSION: EXPANDING THERAPEUTIC OPTIONS


Chairs:
W.S. Aronow, Valhalla, NY, USA
Z.S. Galis, Bethesda, MD, USA

 
16:45 2016 UPDATE ON TREATMENT OF HYPERTENSION (Invited Lecture)
W.S. Aronow, Westchester Medical Center/New York Medical College, Valhalla, NY, USA
304
17:00 NITRIC OXIDE, GI PROTEINS AND REGULATION OF BLOOD PRESSURE (Invited Lecture)
E. Hossain, O. Sarkar, Y. Li, M.B. Anand-Srivastava, University of Montreal, Montreal, Quebec, Canada
305
17:15 HYPERTENSION UPDATE: QUO VADIMUS? (Invited Lecture)
Z.S. Galis, Vascular Biology and Hypertension, National Heart Lung and Blood Institute, Bethesda, MD, USA
306
17:30 THERAPEUTIC, PREVENTIVE AND PROGNOSTIC ASPECTS OF EXERCISE IN HYPERTENSION (Invited Lecture)
P. Kokkinos, Veterans Affairs Medical Center, Washington, DC, USA and Georgetown University School of Medicine, Washington, DC, USA
308
17:45 EXERCISE RELATED HYPERTENSION (ERH) MAY NOT BE A BENIGN PHENOMENON (Invited Lecture)
Y. Charuzi, J.M. Mirocha, Cedars Sinai Medical Center, LA, USA
310
18:00 UPDATE ON EFFECT OF ISOLATED SYSTOLIC VERSUS SYSTOLIC-DIASTOLIC HYPERTENSION IN OLDER ADULTS
A. Tsimploulis, S. Weerakoon, A. Ahmed, Georgetown University / Washington Hospital Center, USA
311
18:15 GENOME-WIDE ASSOCIATION STUDY ON SALTINESS AND ASSOCIATION OF TOPRANKING SNPS WITH BLOOD PRESSURE
D. Corella, R. Fernandez-Carrion, R. Barragan-Arnal, A. Rodrigues-Cruz, I. Gonzalez-Monje, L. Quiles, J.V. Sorli, J.M. Ordovas, O. Coltell, CiberOBN, Madrid, Spain
312
SUNDAY, JULY 31, 2016
16:45 - 19:00   HALL C
  S32  Session:
ARRHYTHMIA II: SUDDEN CARDIAC DEATH / ADVANCES IN IMPLANTABLE RHYTHM DEVICE THERAPY

Chairs:
J.R. Gimbel, Cleveland, OH, USA
H. Paydak, Little Rock, AR, USA
 
16:45 ICD-FORUM - WEB-BASED PSYCHOSOCIAL SUPPORT FOR PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
S.M. Schulz, R. Zniva, O. Ritter, C. Wacker, M. Jack, G. Groschup,
T. Deneke, P. Pauli, Comprehensive Heart Failure Center - Wuerzburg, University Hospital Wuerzburg, Germany
313
17:00 THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: FIRST SINGLECENTER EXPERIENCE WITH OTHER CARDIAC IMPLANTABLE ELECTRONIC DEVICES
J. Kuschyk, B. Rudic, S. Roeger, E. Tueluemen, V. Liebe,
M. Borggrefe,University Medical Center Mannheim, DZHK (German Centre for Cardiovascular Research First Medical Department,) partner site Mannheim, Germany
314
17:15 THE INCIDENCE OF TORSADES DE POINTES AFTER PROPOFOL EXPOSURE
V. Abrich, H. Ramakrishna, A. Mehta, F .Mookadam, K. Srivathsan, Mayo Clinic Arizona, Phoenix, AZ, USA
315
17:30 INTRA-HIS BLOCK RARELY PROGRESS TO PACEMAKER DEPENDENCY: A CASE SERIES
L. Ragupathi, D. Johnson, B.B. Pavri, Thomas Jefferson University Hospital, Philadelphia, PA, USA
316
17:45 LONG-TERM COMPLICATIONS OF EPICARDIAL PACING WIRES ABANDONED FOLLOWING CARDIAC SURGERY
A. Singh, A. Shi, H. Vefali, S. Agrawal, A. Sinha, J. Shirani St Lukes University Hospital, Bethlehem, PA, USA
317
18:00 SAFETY AND EFFICACY OF TRANSVENOUS EXTRACTION OF PACEMAKER AND CARDIOVERTER-DEFIBRILLATOR LEADS
H. Vefali, M. Durkin, A. Singh, S. Agrawal, S. Nanda, D. Traub, J. Shirani, St. Luke's University Health Network, Bethlehem, PA, USA
318
18:15

DEVICE IMPLANTATION CONUNDRUM: OPTIMAL MANAGEMENT OF A PATIENT WITH MIXED PHENOTYPE CHANNELOPATHY
H. Latt, J. Evans, University of Nevada, Reno, Nevada, USA

319
18:30

INAPPROPRIATE SHOCKS DUE TO CHATTERING OF THE LEADS FROM AN INVESTIGATIONAL DEVICE FOR CARDIAC CONTRACTILITY MODULATION AND A DEFIBRILLATION LEAD
T.T. Aung, A. Wase, J. Pollock, Wright State University, Dayton, OH, USA

320
18:45 A COMPARISON OF ACTIVE AND PASSIVE LEAD IMPLANTATION: IS OPERATING EXPERIENCE A FACTOR?
J. Basu, C. Wrigley, R. Soar, W. Orr, Royal Berkshire Hospital, Reading, UK
321
SUNDAY, JULY 31, 2016
16:45 - 19:15   HALL D
  S33  Session:
ACUTE CORONARY SYNDROME: FROM BENCH TO BEDS

Chairs:
M-R. Movahed, Tucson, AZ, USA
Y. Ueda, Osaka, Japan
 
16:45 INCIDENCE AND RISK FACTORS FOR AKI PRE-CARDIAC CATHERIZATION IN PATIENTS PRESENTING WITH STEMI
M. Ashukem, J. Cohen, J. Diamond, J. Badlani, M. Calfa, C. Mendoza, University of Miami/Jackson Memorial Hospital, Miami, FL, USA
322
17:00 CORONARY COLLATERALS ARE NOT CARDIOPROTECTIVE IN MULTIETHNIC STEMI PATIENTS AFTER REVASCULARIZATION
A. Avezbadalov, A. Jaiswal, E.N. Moustakakis, C.H. Park, A.J. Buda, New York Presbyterian Queens, Weill Cornell Medical College, New York, NY, USA
323
17:15 THE HIGH-DEGREE ATRIOVENTRICULAR BLOCK REMAINS A SEVERE PROGNOSTIC MARKER IN THE PRIMARY PERCUTANEOUS CORONARY INTERVENTION ERA
P. Dobes, Glenfield Hospital Leicester, University Hospitals of Leicester NHS Trust, Leicester, UK
324
17:30 IMAGING DEBAKEY’S DEBACLE: AN UNUSUAL CULPRIT FOR ST ELEVATION
A. Alsaad, O. Odunukan, Mayo Clinic, Jacksonville, FL, USA
325
17:45 RELATION BETWEEN THE LEVEL OF RED BLOOD CELL DISTRIBUTION AND ELECTROCARDIOGRAM CHANGES AND ECHOCARDIOGRAPHIC WALL MOTION SCORE INDEX IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
M. Toufan, M. Rezazadehsaatlou, Tabriz University of Medical Sciences, Tabriz, Eastern Azerbaijan, Iran
326
18:00 SEVERE CHEST PAIN MIMICKING ACUTE CORONARY SYNDROME IN A DIABETIC PATIENT WITH MYASTHENIA GRAVIS
A. Chiriac, S.V. Pislaru, P.A. Pellikka, Mayo Clinic, Rochester, MN, USA
327
18:15 ACUTE LEFT MAIN THROMBOSIS DURING EXERCISE TESTING
A. Quddus, A. Smith, A. Singh, Y. Manda, P. Puleo, J. Shirani, Department of Cardiology, St. Luke’s University Health Network, Bethlehem, PA, USA
328
18:30

IS THERE ANY CORRELATION BETWEEN PLATELET INDICES WITH EXTENT OF CORONARY ARTERY INVOLVEMENT IN ISCHEMIC HEART DISEASES?
M.H. Adel, M. Seyedian, M. Jafarsalehi, M. Nourizadeh, S. Bagheri, M. Nourizadeh, P. Nabavizadeh Rafsanjani, A. Shams Akhtari, Ahwaz Jundishapur University of Medical Sciences

329
18:45

CORRELATION BETWEEN ELECTROCARDIOGRAPHIC CHANGES AND CORONARY ANGIOGRAPHY FINDINGS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND SINGLE-VESSEL DISEASE
A. Sanaani, W.S. Aronow, R. Paudel, H. Cooper, Westchester Medical Ctr/New York Medical College, Valhalla, NY, USA

330
19:00 LEFT BUNDLE BRANCH BLOCK: IS IT TIME TO RECONSIDER THE CRITERIA FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION?
J. Basu, M. Mikhail, T. Realey, W. Orr, Royal Berkshire NHS Foundation Trust, Reading, UK
038

 

 

Saturday,
July 30, 2016
Sunday,
July 31, 2016
Monday,
August 1, 2016
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions


 

Affiliated with


 

    international academy of cardiology

 IACS